2016 American Transplant Congress

Tuesday, June 14, 2016

3:42pm-3:54pm

Ex Situ Perfusion of a Human Limb for 24 Hours.

N. Werner,¹ F. Alghanem,¹ S. Rakestraw,¹ B. Nicely,² A. Olszewksi,² S. Rudich,² A. Rojas-Pena,¹ J. Magee,¹ K. Ozer.³

Concurrent Session: Clinical Vascularized Composite Allotransplantation  •  Room 102

3:42pm-3:54pm

Have We Gone Too Far Defining Performance Outliers? One-Third of Kidney Transplant Programs Now Identified for Low Performance within Three Years.

J. Schold,¹ C. Miller,¹ M. Henry,² L. Buccini,¹ S. Flechner,¹ D. Goldfarb,¹ E. Poggio,¹ K. Andreonni.³

Concurrent Session: Living Donation and Transplant: Operational and Economic Factors  •  Room 311

3:42pm-3:54pm

Hematopoietic Cell Transplant and Solid Organ Transplantation: A First Report of the U.S. Experience.

M. Gupta, M. Levine, P. Abt.

Concurrent Session: PTLD and Malignancies  •  Room 206

3:42pm-3:54pm

HLA Class II and BK Virus Reactivation in Renal Transplant Recipients.

P. Shah,¹ K. Anderson,² M. Aubrey,² C. Roark,² B. Freed,² A. Wiseman.¹

Concurrent Session: Kidney: Polyomavirus  •  Room 210

3:42pm-3:54pm

Mortality and Graft Loss Attributable to Readmission Following Kidney Transplantation.

E. King, M. Bowring, L. Kucirka, M. McAdams-DeMarco, A. Massie, D. Segev.

Concurrent Session: Kidney: Length of Stay/Readmission  •  Room 302

3:42pm-3:54pm

Profiling Metabolic Differences Between Graft- vs. Pathogen-Elicited CD8⁺ T Cell Responses.

A. Karp, M. Wagener, J. Robertson, M. Ford.

Concurrent Session: T Cell Biology and Alloimmunity: Animal Models  •  Room 310

3:42pm-3:54pm

Serelaxin Decreases the Severity of Cold Ischemia-Reperfusion Injury After Liver Transplantation in Mice.

S. Kageyama, K. Nakamura, R. Busuttil, J. Kupiec-Weglinski.

Concurrent Session: Ischemic Injury and Organ Preservation: Animal Models  •  Room 313

3:42pm-3:54pm

TGFb in Regulatory B Cells-Dependent Tolerance.

H. Deirawan, L. Kojima, L. Washburn, J. Markmann, J. Kim.

Concurrent Session: Allograft Tolerance 2: Animal Models  •  Room 309

3:42pm-3:54pm

The Impact of CMS Policy on Delisting of "Too Sick" Liver Transplant Candidates.

N. Dolgin, B. Movahedi, P. Martins, A. Bozorgzadeh.

Concurrent Session: Liver: MELD, Allocation and Donor Issues (DCD/ECD) 1  •  Room 304

3:42pm-3:54pm

Treatment of Hepatitis C Viral Infection with Novel Direct Acting Antivirals in Kidney Transplant Recipients – Single Center Experience.

K. Hatahet,¹ M. Ghanta,¹ A. Gillespie,¹ I. Lee,¹ H. El-Halawany,² K. Qureshi,² K. Lau,³ S. Karhadkar,³ A. Di Carlo,³ S. Constantinescu,¹ S. Rao.¹

Concurrent Session: It's Just Not the Donor: Impact of Recipient Factors on Outcomes  •  Ballroom A